Literature DB >> 7953914

Acute leukemia in adults: recent developments in diagnosis and treatment.

S M Devine1, R A Larson.   

Abstract

Major advances in the diagnosis, classification, and treatment of adult acute leukemias have resulted in significant increases in the number of complete remissions and long-term disease-free survivors. Despite these improvements, most adult patients with acute leukemias still eventually die from their disease or complications of its treatment. New experimental and clinical approaches used to diagnose, monitor, and treat these diseases hold promise for further increased cure rates in the future. This article reviews the classification, immunobiology, cytogenetics, diagnosis, and treatment of adult acute leukemias and describes new directions being taken toward their cure.

Entities:  

Mesh:

Year:  1994        PMID: 7953914     DOI: 10.3322/canjclin.44.6.326

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  6 in total

Review 1.  Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.

Authors:  C J Dunn; K L Goa
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

2.  Expression of topoisomerase IIIalpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody.

Authors:  A J Lodge; J J Anderson; S W Ng; F Fenwick; M Steward; B Haugk; C H Horne; B Angus
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

3.  Acute myelogenous leukemia mimicking fulminant periorbital cellulitis.

Authors:  Abbas Bagheri; Alireza Abrishami; Saeed Karimi
Journal:  J Ophthalmic Vis Res       Date:  2013-10

4.  Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.

Authors:  Mounia Elidrissi Errahhali; Manal Elidrissi Errahhali; Redouane Boulouiz; Meryem Ouarzane; Mohammed Bellaoui
Journal:  BMC Cancer       Date:  2016-02-25       Impact factor: 4.430

5.  Hyperuricemia might be an early manifestation of undiagnosed adult leukemia in a population-based cohort study.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Biomedicine (Taipei)       Date:  2020-03-28

Review 6.  Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy.

Authors:  Yanxin Xu; Chen Chen; Yaxin Guo; Shengyun Hu; Zhenqiang Sun
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.